{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/170f7fea-3078-4315-9c6b-57b666e73855/6a4ee29bfe878dc8e2546b5e?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"As Drama at Trump's FDA Subsides, Doubts and Damage Linger","description":"<p>We talk with STAT News reporter Lizzy Lawrence about the agency’s recent turmoil and its hunt for a new leader. </p><p><br></p><p>Guest:</p><p><br></p><ul><li><a href=\"https://www.statnews.com/staff/lizzy-lawrence/\" rel=\"noopener noreferrer\" target=\"_blank\">Lizzy Lawrence</a>, FDA Reporter, STAT News</li></ul><p><br></p><p>Learn more: Read the full reporting and explore additional resources <a href=\"https://tradeoffs.org/2026/07/09/as-drama-at-trumps-fda-subsides-doubts-and-damage-linger/\" rel=\"noopener noreferrer\" target=\"_blank\">on our website</a>.</p><p><br></p><p>Want more Tradeoffs? Join more than 5,500 readers who trust Tradeoffs for clear, deeply reported health policy insights. <a href=\"https://tradeoffs.org/about/subscribe/?utm_campaign=show_notes&amp;utm_source=web&amp;utm_medium=referral\" rel=\"noopener noreferrer\" target=\"_blank\">Sign up for our free weekly newsletter</a>.</p><p><br></p><p>Tradeoffs helps you cut through the noise with clear, deeply reported journalism on the forces driving health care's toughest choices — reporting you won't find anywhere else. If our work helps you stay informed, <a href=\"https://tradeoffs.fundjournalism.org/donate/?utm_campaign=show_notes&amp;utm_source=web&amp;utm_medium=referral\" rel=\"noopener noreferrer\" target=\"_blank\">support it with a donation today</a>.</p><p><br></p><p>This episode was produced by Leslie Walker, edited by Ryan Levi and Dan Gorenstein, and mixed by Cedric Wilson.</p><p><br></p><p>The Tradeoffs theme song was composed by Ty Citerman. Additional music this episode from Blue Dot Sessions and Epidemic Sound.</p><p><br></p><p>Special thanks to Alex Hogan.</p><p><br></p><p>Tradeoffs reporting for this story was supported, in part, by Arnold Ventures.</p>","author_name":"Tradeoffs"}